Sumitomo Chemical India Limited has announced a change in its senior management personnel, with Mr. Yoshihisa Inoue set to complete his deputation term as Sr. Vice President (Manufacturing) on March 31, 2026. The company disclosed this information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management Transition Details

Mr. Yoshihisa Inoue, who was deputed to the company by Sumitomo Chemical Company, Limited, Japan, the parent company, has been serving as part of the core senior management team in his role as Sr. Vice President (Manufacturing). His deputation term will conclude on March 31, 2026, after which he will cease to be a senior management personnel of the company.

Regulatory Compliance

The announcement was made in compliance with SEBI's listing obligations and disclosure requirements. The company has formally notified both BSE Limited and The National Stock Exchange of India about this senior management change, ensuring transparency with stakeholders and regulatory authorities.

Company Structure

As part of the disclosure, the company operates under the parent company Sumitomo Chemical Company, Limited, Japan, which deputes senior executives to manage key operational functions. Mr. Inoue's role in manufacturing operations has been part of this strategic management structure, reflecting the integrated approach between the Indian subsidiary and its Japanese parent company.

Sumitomo Chemical India Limited released its unaudited financial results for the quarter and nine months ended 31st December 2025, presenting a mixed performance picture with quarterly challenges offset by strong nine-month growth. The agro-chemicals company's Board of Directors approved these results at a meeting held on 27th January 2026.

Quarterly Performance Shows Decline

The company's standalone performance for Q3FY26 reflected challenging market conditions. Net profit declined by 11.2% year-on-year to ₹748.26 million compared to ₹843.11 million in Q3FY25. Revenue from operations also decreased by 11.4% to ₹5,517.58 million from ₹6,224.29 million in the corresponding quarter of the previous year.

Nine-Month Results Demonstrate Resilience

Despite quarterly headwinds, the nine-month performance showcased the company's underlying strength. For the period ended 31st December 2025, net profit increased by 7.2% to ₹4,325.29 million compared to ₹4,035.41 million in the corresponding nine-month period of FY25. Revenue from operations grew by 3.7% to ₹25,142.71 million from ₹24,255.67 million in the previous year.

Exceptional Items Impact Results

The quarterly results were significantly affected by exceptional items amounting to ₹151.86 million. These charges relate to the implementation of four Labour Codes notified by the Government of India on 21st November 2025, consolidating 29 existing labour laws. The company classified this regulatory-driven impact as exceptional due to its non-recurring nature.

Consolidated Performance Mirrors Standalone Trends

The consolidated results, which include two subsidiary companies, followed similar patterns. Consolidated net profit for Q3FY26 stood at ₹758.00 million compared to ₹874.30 million in Q3FY25, while nine-month consolidated net profit reached ₹4,316.59 million versus ₹4,066.58 million in the previous year. Consolidated revenue for the quarter was ₹5,679.78 million against ₹6,419.19 million in Q3FY25.

Operational and Regulatory Considerations

The company operates exclusively in the agro-chemicals segment, with business performance remaining seasonal and dependent on monsoon and climatic conditions. Sumitomo Chemical continues to monitor ongoing legal proceedings regarding Glyphosate usage restrictions, with petitions filed before the Delhi High Court challenging government notifications from October 2022. The company maintains that these regulations will not be implemented until petition disposal.

The financial results were reviewed by BSR & Co. LLP, Chartered Accountants, and approved by the Audit Committee before Board approval. The company's paid-up equity share capital remains unchanged at ₹4,991.46 million with a face value of ₹10 per share.